ADT
12
2
MA
60
5
HPQ
55
3
CTSH
55
3
THC
52
9
PLD
35
5
HSIC
42
2
JPM
59
6
DTE
49
16
ITW
45
2
ROST
60
3
IVZ
42
13
HBAN
47
7
CTAS
36
8
AES
47
4
ORCL
49
3
PX
56
3
AMT
30
2
RL
73
5
XEL
48
11
ADT
12
2
MA
60
5
HPQ
55
3
CTSH
55
3
THC
52
9
PLD
35
5
HSIC
42
2
JPM
59
6
DTE
49
16
ITW
45
2
ROST
60
3
IVZ
42
13
HBAN
47
7
CTAS
36
8
AES
47
4
ORCL
49
3
PX
56
3
AMT
30
2
RL
73
5
XEL
48
11
Financhill
Back

CNS Pharmaceuticals Vs. Nukkleus Industry Stock Comparison

Sell
36

CNSP
CNS Pharmaceuticals

Last Price:
$0.11
Seasonality Move:
-46.41%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
36
CNS Pharmaceuticals (CNSP) is a Sell

Is CNS Pharmaceuticals a Buy, Sell or Hold?

  • The current CNS Pharmaceuticals [CNSP] share price is $0.11. The Score for CNSP is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CNSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNSP Stock Price Chart

What is CNS Pharmaceuticals's stock price today?

  • The CNS Pharmaceuticals share price today is $0.11
    The current trend is relatively stagnant and CNSP is experiencing slight buying pressure.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

CNSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 47.71 Sell
Chaikin Money Flow: 288566 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.1 - 0.12) Buy
Bollinger Bands (100): (0.11 - 0.17) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

CNSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.11 Buy
20-day SMA: 0.11 Buy
50-day SMA: 0.12 Sell
200-day SMA: 4.42 Sell
8-day EMA: 0.11 Buy
20-day EMA: 0.11 Buy
50-day EMA: 0.19 Sell
200-day EMA: 13.27 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

CNS Pharmaceuticals Earnings Growth & CNSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CNS Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):